THE CHINWAGY BUZZ · FIRST VERIFIED WORD
Takeda and Halozyme expand global collaboration on vedolizumab delivery technology
WHAT CHINWAGY KNOWS
The collaboration
is confirmed.
Takeda announced a global collaboration and license agreement with Halozyme granting Takeda exclusive access to Halozyme’s ENHANZE drug-delivery technology for use with vedolizumab, marketed as ENTYVIO.
- Current status
- Official collaboration
- Known availability
- The published source describes the collaboration; timing details remain under review.
- Place
- Osaka, Japan
- Source checked
- September 17, 2026
FOLLOW THE STORY